Tellimer

HK : Pentamaster - Short-term challenges

The recent lockdowns and tight supply of components have made it a challenge for Pentamaster to develop business and deliver products and services in the near term. Pentamaster management has seen increasing activity in the electro optical (smartphone), auto and semi-conductor segments. The medical devices segment is expected to make a meaningful contribution only by early 2023 and to be a medium- and long-term growth driver for Pentamaster. We lowered our net profit forecasts by 4.1% in 2021F and 0.1% for 2022F after factoring in slower revenue growth. We maintain our ADD rating, with a target price of HK$2.82, based on 18x 2021F P/E (unchanged). The cut in target price is due mainly to lower net profit forecasts.


Most Viewed See latest
Disclosures

This publication is being distributed by Tellimer solely for information purposes irrespective of a particular user's means, financial situation or investment objectives. The information does not con...

Full Tellimer disclaimers